Clinical Pharmacology Details


PROPRANOLOL HYDROCHLORIDE


View Drug Forms

Indications & Dose:

Thyrotoxicosis (adjunct) l



Adult: 10–40 mg 3–4 times a day


Thyrotoxic crisis l



Adult: 1 mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum total dose is 5mg in anaesthesia; maximum 10 mg per course


Hypertension l



Adult: Initially 80 mg twice daily, dose should be increased at weekly intervals as required; maintenance 160–320 mg daily


Prophylaxis of variceal bleeding in portal hypertension 



Adult: Initially 40 mg twice daily, then increased to 80 mg twice daily (max. per dose 160 mg twice daily), dose to be adjusted according to heart rate


Phaeochromocytoma (only with an alphablocker) in preparation for surgery l



Adult: 60 mg daily for 3 days before surgery


Phaeochromocytoma (only with an alphablocker) in patients unsuitable for surgery l



Adult: 30 mg daily


Angina l



Adult: Initially 40 mg 2–3 times a day; maintenance 120–240 mg daily


Hypertrophic cardiomyopathy Anxiety tachycardia l



Adult: 10–40 mg 3–4 times a day


Anxiety with symptoms such as palpitation, sweating and tremor l



Adult: 40 mg once daily, then increased if necessary to 40 mg 3 times a day


Prophylaxis after myocardial infarction l



Adult: Initially 40 mg 4 times a day for 2–3 days, then 80 mg twice daily, start treatment 5 to 21 days after infarction


Essential tremor l



Adult: Initially 40 mg 2–3 times a day; maintenance 80–160 mg daily


Migraine prophylaxis



Adult: 80–240 mg daily in divided doses


Arrhythmias  



Adult: 10–40 mg 3–4 times a day



Adult: 1 mg, to be given over 1 minute, dose may be repeated if necessary at intervals of 2 minutes, maximum 10 mg per course (5mg in anaesthesia)

Contraindications:

Side Effects:

CNS: Depression, dizziness, drowsiness, fatigue, hallucinations, insomnia, lethargy, memory loss, mental changes, strange dreams
CV: Bradycardia, CHF, cold extremities, postural hypotension, profound hypotension, 2nd or 3rd degree heart block
EENT: Dry, burning eyes; sore throat; visual disturbances
GI: Diarrhea, dry mouth, elevated LFTs, ischemic colitis, mesenteric arterial thrombosis, nausea, vomiting
GU: Impotence, sexual dysfunction
HEME: Agranulocytosis, thrombocytopenia
METAB: Hyperglycemia, hyperlipidemia (increase TG, total cholesterol, LDL; decrease HDL), masked hypoglycemic response to insulin (sweatingexcepted)
RESP: Bronchospasm, dyspnea, wheezing
SKIN: Alopecia, pruritus, rash

Cautions:

Precautions:

nesthesia/surgery (myocardial depression), avoid abrupt withdrawal, bronchospastic airways, congestive heart failure, diabetes mellitus, hyperthyroidism/ thyrotoxicosis (atenolol, unlike propranolol, does not decrease T3 levels), concurrent clonidine (discontinue atenolol several days prior to withdrawal of clonidine), peripheral vascular disease, renal disease.


PREGNANCY & BREAST-FEEDING: Use with caution.
OLD AGE: May be used

Interaction:

Drugs
alfa-1 adrenergic blockers:Potential enhanced first dose response (marked initial drop in blood pressure), particularly on standing (especially prazocin)


Amiodarone: Bradycardia, cardiac arrest, ventricular dysrhythmia shortly after initiation of beta-blocker


Antidiabetic: Masked symptoms of hypoglycemia, prolonged recovery of normoglycemia
Antipyrine: Increased antipyrine concentrations


Barbiturates, rifampin: Reduced concentrations of propranolol


Beta-agonists: Antagonistic effects


Calcium channel Mockers: Increased concentrations of propranolol; increased bioBrands Available with Cost of nifedipine
Chlorpromazine: Additive hypotensive effects and grand mal seizures; chlorpromazine decreases the clearance of oral propranolol by 25% to 32%, resulting in increased propranolol bioBrands Available with Cost


Cimetidine, etintidine, fluoxetine, propoxyphene, propafenone, quinidine, quinolones: Increased propranolol concentrations


Clonidine, guanahenz, guanfacine: Exacerbation of hypertension upon withdrawal of clonidine
Cocaine: Potentiation of cocaine induced coronary vasospasm


Contrast media: Increased risk anaphylaxis Digitalis glycosides: Increased digoxin concentrations


Dihydroergotamine, ergotamine: May result in excessive vasoconstriction
Fluvoxamine: Increased propranolol serum concentrations; increased risk of bradycardia and hypotension
Epinephrine: Enhanced pressor response to epinephrine


Flecainide: Increased propranolol and flecainide concentrations; additive negative inotropic effects


Hydralazine: Increases oral bioBrands Available with Cost of propranolol (high clearance and lipophilic PB-blockers) increasing risk of adverse effects
Hydrochlorothiazide: Exaggerated hyperglycemic response


Lidocaine: Increased lidocaine concentrations 


Local anesthetics: Enhanced sympathomimetic side effects of epinephrine-containing local anesthetics


Neostigmine, physostigmine, tacrine: Additive bradycardia


Neuroleptics: Increased plasma concentrations of both drugs


NSAIDs: Reduced hypotensive effect of propranolol
Phenylephrine: Predisposition to acute hypertensive episodes


Theophylline: Increased theophylline concentrations; antagonistic pharmacodynamic effects

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: